Skip to main content
Clinical Trials/TCTR20231005003
TCTR20231005003
Completed
Phase 2

Effect of Lidocaine Gel for Pain Relief during Endometrial Sampling in Postmenopausal bleeding: Randomized Controlled Trial

/A0 sites72 target enrollmentOctober 5, 2023

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Post menopausal bleeding
Sponsor
/A
Enrollment
72
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 5, 2023
End Date
June 23, 2023
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • women who were diagnosed with post menopausal bleeding and were literate, mature, and stable enough to do the visual analog score (VAS).

Exclusion Criteria

  • 1\.allergy to lidocaine jelly
  • 2\.unstable vital signs for example systolic blood pressure (SBP) lower than 90 mmHg., diastolic blood pressure (SBP) lower than 60 mmHg., pulse rate more than 120 bpm.,
  • 3\.patient unconsciousness or unable to answer the question and pain score.

Outcomes

Primary Outcomes

Not specified

Similar Trials